Chrontech Pharma AB Receives Extended Offer From a Group of Shareholder
4/30/2013 11:39:21 AM
More...
|
Interim Report January - September 2012 Chrontech Pharma AB
10/26/2012 6:34:15 AM
More...
|
Inovio Pharmaceuticals (Formerly Known as Inovio Biomedical Corporation) (INO), TRANSGENE (TRGNY) and Chrontech Pharma AB to Collaborate on Heterologous Prime-Boost Therapeutic Vaccination Against Hepatitis C
4/18/2011 7:24:45 AM
More...
|
Inovio Pharmaceuticals (Formerly Known as Inovio Biomedical Corporation) (INO)' Partner Chrontech Pharma AB Initiates Phase II Clinical Trial of Hepatitis C Virus DNA Vaccine Using Inovio's Electroporation Delivery Technology
3/14/2011 8:17:09 AM
More...
|
Chrontech Pharma AB Receives a Six Months’ Extension of Its Option to Buy Back in ChronSeal(R)
5/12/2010 9:30:38 AM
More...
|
Chrontech Pharma AB: Interim Report ChronTech Pharma January-March 2010
4/28/2010 9:49:12 AM
More...
|
Chrontech Pharma AB: ChronSeal(R) Study Completed and Continuing Positive Results in the Follow-up of the ChronVac-C(R) Study
4/28/2010 7:03:23 AM
More...
|
Tripep Changes Name to Chrontech Pharma AB
3/19/2010 9:12:09 AM
More...
|
Tripep's New Rights Offering Oversubscribed
12/23/2009 9:11:19 AM
More...
|
Tripep Receives Approval for Expanding the ChronVac-C(R) Study with One More Vaccination
12/3/2009 9:37:32 AM
More...
|
|